Applied DNA Schedules Fiscal 2018 First Quarter Financial Results Conference Call for Thursday, February 8, 2018 at 4:30 PM ET
January 30 2018 - 5:30AM
Business Wire
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it
plans to release financial results for its fiscal 2018 first
quarter ended December 31, 2017 after market close on Thursday,
February 8, 2018. In conjunction with the release, the Company has
scheduled a conference call at 4:30 p.m. Eastern Time that will
also be broadcast live over the internet.
What:
Applied DNA’s Fiscal 2018 First Quarter
Financial Results Conference Call
When:
Thursday, February 8, 2018, at 4:30 p.m. Eastern Time
Where:
Via phone by dialing +1 844-887-9402 or +1
412-317-6798 and ask for the Applied DNA call; via webcast.
A telephonic replay of the conference call will be available for
one day and may be accessed by calling +1 877-344-7529 or +1
412-317-0088 with the passcode 10115974. The webcast will be
archived in the Investors section of the company’s website.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics. The Company makes life real and safe
by providing innovative, molecular-based technology solutions and
services that can help protect products, brands, entire supply
chains, and intellectual property of companies, governments and
consumers from theft, counterfeiting, fraud and diversion.
The proprietary DNA-based CertainT® platform can be
used to identify, tag, test, and track products, to help assure
authenticity, origin, traceability, sustainability and quality of
products. SigNature® DNA describes the core technology
ingredient that is at the heart of a family of uncopyable, security
and authentication solutions such as SigNature®T and fiberTyping®,
targeted towards textiles and apparel, BackTrac® and DNAnet®,
for anti-theft and loss prevention, and digitalDNA®, providing
powerful track-and-trace. All provide a forensic chain of evidence,
and can be used to prosecute perpetrators. Applied DNA Sciences is
also engaged in the large-scale production of specific DNA
sequences using the polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Forward Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
28, 2017, which is available at www.sec.gov. APDN undertakes
no obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180130005181/en/
Investors:LHA Investor RelationsSanjay M. Hurry,
212-838-3777shurry@lhai.comorWeb:www.adnas.com | twitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024